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We describe a recessively inherited frontonasal malformation characterized by a distinctive facial appearance, with hypertelorism, wide
nasal bridge, short nasal ridge, biﬁd nasal tip, broad columella, widely separated slit-like nares, long philtrum with prominent bilateral
swellings, and midline notch in the upper lip and alveolus. Additional recurrent features present in a minority of individuals have been
upper eyelid ptosis and midline dermoid cysts of craniofacial structures. Assuming recessive inheritance, we mapped the locus in three
families to chromosome 1 and identiﬁed mutations in ALX3, which is located at band 1p13.3 and encodes the aristaless-related ALX
homeobox 3 transcription factor. In total, we identiﬁed seven different homozygous pathogenic mutations in seven families. These
mutations comprise missense substitutions at critical positions within the conserved homeodomain as well as nonsense, frameshift,
and splice-site mutations, all predicting severe or complete loss of function. Our ﬁndings contrast with previous studies of the orthol-
ogous murine gene, which showed no phenotype in Alx3/ homozygotes, apparently as a result of functional redundancy with the
paralogous Alx4 gene. We conclude that ALX3 is essential for normal facial development in humans and that deﬁciency causes a clini-
cally recognizable phenotype, which we term frontorhiny.Formation of the human face is an exquisitely orchestrated
developmental process involving multiple tissue swell-
ings—the frontonasal, medial and lateral nasal, and maxil-
lary and mandibular prominences —derived from the
neural crest.1During a critical periodbetween4 and8weeks
of human fetal development, these processesmust undergo
cell proliferationand tissue fusion to form theorbital, nasal,
and oral structures.1,2 Disturbance to this developmental
sequence causes frontonasal malformation (FNM), a very
heterogeneous group of disorders characterized by combi-
nations of hypertelorism, abnormal nasal conﬁguration,
and oral, palatal, or facial clefting, sometimes associated
with facial asymmetry, skin tags, ocular or cerebral malfor-
mations, widow’s peak, and anterior cranium biﬁdum.3–9
Surgical management of FNM often poses substantial
challenges.
Most cases of FNMare sporadic, andno cause canbe iden-
tiﬁed.However, disruption to development of the fetal face,
caused by transient hypovolemia, haemorrhage into facial
tissues, amniotic bands, or teratogens, is suspected to
contribute in many cases. In addition, a marked increase
in the frequency of monozygotic twinning (with discor-
dance for FNM in the twins) has been noted, suggesting
that the twinning process itself may sometimes precipitate
themalformation.10Genetic causes of FNMare identiﬁed in698 The American Journal of Human Genetics 84, 698–705, May 15only aminority of cases;mutations of EFNB1 (MIM300035)
incraniofrontonasal syndrome (MIM304110) represent the
only consistent association.11,12 No mutation of a speciﬁc
gene(s) has hitherto been identiﬁed in isolated FNM.
We initially identiﬁed three individuals from two families
(subjects 1 and 2 in family 1 and subject 3 in family 2) who
shared a similar distinctive facial appearance (Figures 1A
and 1C). Subjects 1 and 2 were siblings (male and female,
respectively), born to parents who were not known to be
related but who originated from adjacent valleys in
Morocco; the family history elicited from subject 3, a
sporadically affected male from Algeria, was imprecise, but
distant parental consanguinity was indicated (Figure 2A).
Ethical approval for genetic research and human embryo
studies was obtained from the Oxfordshire Research Ethics
Committee B (C02.143).
Based on the hypothesis of a shared genetic etiology
resulting from inheritance of autosomal-recessive muta-
tions, we undertook a whole-genome linkage analysis
by using the GeneChip Human Mapping 250K Sty Array
(Affymetrix) and samples from family 1 (subjects 1 and 2,
both parents, and three unaffected siblings) and subject
3. We assumed recessive inheritance with full penetrance,
a disease allele frequency of 0.0001, and that the parents of
affected individuals in families 1 and 2 were each related as1Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; 2Department of Plastic and Reconstructive Surgery, 3Department
of Clinical Genetics, Erasmus Medical Center, 3000 CB Rotterdam, The Netherlands; 4Cologne Center for Genomics and Institute for Genetics, 5Cologne
Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, D-50674 Cologne, Germany; 6Department of
Clinical Genetics, 7North Thames Cleft Centre, Great Ormond Street Hospital for Children, London WC1N 3JH, UK; 8Centre for Human Genetics, Banga-
lore 560 066, India; 9Molecular Medicine Unit, 10Clinical and Molecular Genetics Unit, 11Neural Development Unit, 12Human Developmental Biology
Resource, Institute of Child Health, University College London, LondonWC1N 1EH, UK; 13Department of Pediatrics, Academic Medical Centre, University
of Amsterdam, 1105 AZ Amsterdam, The Netherlands; 14Department of Clinical Genetics, 15Department of Plastic and Reconstructive Surgery, Oxford Rad-
cliffe Hospitals NHS Trust, Oxford OX3 9DU, UK; 16Center for Molecular Medicine Cologne, University of Cologne, D-50931 Cologne, Germany
*Correspondence: awilkie@hammer.imm.ox.ac.uk
DOI 10.1016/j.ajhg.2009.04.009. ª2009 by The American Society of Human Genetics. All rights reserved., 2009
Figure 1. Phenotype of Individuals with Homozygous ALX3
Mutations
(A and B) Subject 1. Facial appearance at an age of 2 days (A).
Coronal CT section at 6 years (B); note broadened dysmorphic
ethmoid bone (arrow) and apparent continuities between nasal
cavity and brain (arrowheads).
(C–E) Subject 3, pre-operative three-dimensional CT scan at an age
of 30 years. Surface scan (C); anterior and posterior views ([D] and
[E], respectively), note maxillary diastema (arrow in [D]) and
patent sutures with accessory horizontal suture through the occip-
ital bone (arrow in [E]).
(F) Subject 5, three-dimensional CT scan at an age of 5 years. Note
maxillary diastema and five paramedian defects in frontal bone,
corresponding in position to overlying tissue swellings, probably
representing congenital dermoid cysts (arrows).
(G) Subject 6, facial appearance at approximately 6 years.
(H) Subject 7, facial appearance at 1 year.
(I) Subject 8, facial appearance at 2 years.
(J) Subject 9, facial appearance at 2 months.
(K) Subject 10, facial appearance at 4 years. The right eye is pthis-
ical because of an infection.
(L) Subject 11, facial appearance at 2 years.The Amsecond cousins. Using ALLEGRO software13, we identiﬁed
two small genomic regions, on chromosomes 1 (maximum
heterogeneity LOD [HLOD] score of 4.58) and 12
(maximum HLOD score of 4.52), that were homozygous
in affected individuals and consistent with complete
linkage (Figure 2B). The chromosome 1 interval, bounded
by SNPs rs558370 and rs17671169, which were heterozy-
gous in subject 3, encompassed 653 kb and 15 genes; the
chromosome 12 interval, bounded by SNPs rs776195 and
rs9988960, which were heterozygous in subjects 1 and 2,
encompassed 384 kb and ﬁve genes.
The chromosome1 interval contained a strong candidate
gene, ALX3 ([MIM 606014]; related to the aristaless gene
in Drosophila). This gene, located in band 1p13.3, encodes
the ALX homeobox 3 transcription factor, a member of
the Paired class of homeodomain proteins.14 Previous
studies of the murine ortholog, Alx3, had demonstrated
strong expression in the frontonasal mesenchyme.15,16
Although thephenotypeofAlx3/micewasnormal, a cleft
face occurred when these homozygotes were additionally
mutant for the paralogous gene Alx4.16 We ampliﬁed
each of the four exons of ALX3 (primers and ampliﬁcation
conditions are given in Table S1 in the Supplemental
Data) and subjected the products to DNA sequencing and
conﬁrmatory restriction digests. This showed that subjects
1 and 2 were homozygous for a nucleotide substitution
(595-2A > T) in the canonical 30 splice acceptor sequence
of intron 2; subject 3 was homozygous for an exon 3 nucle-
otide substitution (608A>G) encoding anN203Smissense
mutation at a very highly conserved asparagine residue in
helix III of the homeodomain that directly contacts DNA
(Figure 3A, Table 1).17
We extended the analysis to additional patients with
FNM (Figure 2A). Lees et al.18 reported two siblings from
a sibship of seven (subjects 4 and 5, family 3) with a similar
phenotype; analysis of samples from this family by means
of the GeneChip HumanMapping 10K Xba Array (Affyme-
trix) indicated that subjects 4 and 5 were homozygous for a
15.9 Mb region on the short arm of chromosome 1; this
region was bounded by heterozygous SNPs rs10493874
and rs3908929 and included the ALX3 gene (data not
shown). Both affected individuals were homozygous for
the ALX3 mutation 502C > G, encoding a L168V
substitution in the homeodomain. We identiﬁed four
different mutations of ALX3 (all homozygous) in four
previously unpublished families (subjects 6–11, families
4–7) (Figure 3A, Table 1). We either conﬁrmed that the
mutations were heterozygous in both parental samples
by using restriction digests (Table S1 details those cases in
which mutant oligonucleotide primers were employed in
these digests) or used multiplex ligation-dependent probe
ampliﬁcation (MLPA) to demonstrate that the mutant
allele was present in two copies in affected individuals
(MLPA primers and conditions are listed in Table S2).
Although the second linkage signal initially observed on
chromosome 12 raises a possible requirement for the
digenic inheritance of mutations, both the high rate oferican Journal of Human Genetics 84, 698–705, May 15, 2009 699
phenotype recurrence in siblings (Figure 2A) and the
absence of unaffected siblings homozygous for ALX3
mutations (Figure 3A) argue against this; it is more likely
that the chromosome 12 signal represents a type I error.
The genotyping identiﬁed 18 individuals heterozygous
for an ALX3 mutation (Figure 3A), and none of these ex-
hibited unusual facial features suggestive of a manifesting
carrier state.
The mutations are all consistent with severe or complete
loss of DNA binding by the mutant ALX3 protein. The
nonsense (543T>A;Y181X), frameshift (578_581delCTGA;
T193RfsX137), and acceptor splice-site (595-2A > T) muta-
tions are predicted to lead to loss of the DNA-binding helix
III of the homeodomain and thus complete loss of function
(Figure 3B). The other mutations are missense substitutions
that occur at some of the most highly conserved residues
within the 60 amino acid DNA-binding homeodomain;
multiple missense mutations causing loss of function have
been reported previously at the equivalent residues of other
homeodomain transcription factors.19,20 The L168V substi-
tution occurs at position 16 in helix I of the homeodomain,
This leucine residue, which is conserved in the Paired class
and several other classes of human homeodomains,21 is
buried in the hydrophobic core20, and an L132V substitu-
tion at the equivalent position of the SHOX (MIM 312865)
homeodomain showed loss of dimerization and very weak
Figure 2. Pedigrees and Disease Locali-
zation
(A) Pedigrees of families 1–7. (B) Whole-
genome linkage analysis of families 1 and 2.
DNA binding.22 The R183W substitu-
tion occurs at position 31 in helix II;
this arginine residue is highly
conserved in the Paired class and
several other classes of homeodo-
main,21 and its formation of a buried
salt bridge with glutamate at position
42 contributes to the structural integ-
rity of the homeodomain. An equiva-
lentmutation (R298W)was previously
described in the homeodomain of
HOXD13 (MIM 142989); in vitro
studies of several different substitu-
tions of the position 31 arginine
have shown severe or complete loss
of DNA binding.23 The 586C > T
(R196W) substitution occurs at posi-
tion 44 in helix III. Although not very
highly conserved across homeodo-
mains as a whole, this arginine residue
is a common feature in the Paired
class14 and makes contact with
DNA.24 A mutation (R141G) at the
equivalent position of the Paired class
homeodomain of PHOX2B (MIM 603851) was shown to
abolish DNA binding.25 Finally, the N203S substitution
occurs at the position 51 asparagine; this residue directly
contacts an adenine base in bound DNA and is one of the
most highly conserved residues in the entire homeodo-
main.17 Mutations of this asparagine to serine in several
different homeodomain-containing proteins resulted in
severely reduced DNA binding.26 None of the mutations
that we identiﬁed was present in the DNA sequences of
aminimumof 226unrelated control chromosomes ofnorth
European origin.
We used dense surface modeling27 to analyze objectively
the abnormal facial morphology in subjects 3, 4, and 5.
Although this consistently demonstrated maximal tissue
deﬁciency in the midfacial region around the nose and
philtrum, the degree of hypertelorism and mid-face hypo-
plasia was much more marked in subjects 5 and 3 (not
illustrated) compared with subject 4 (Figure 4). In contrast,
subject 4 showed signiﬁcant upward displacement of the
nose and, to a lesser extent, of the supraorbital region
(Figure 4; these differences are also demonstrated in the
dynamic morphs in Movies S1 and S2). These ﬁndings
and the clinical features are consistent with embryonic
tissue disturbance predominantly affecting the frontonasal
and medial nasal prominences;1 the relatively high preva-
lence of congenital dermoid cysts is consistent with700 The American Journal of Human Genetics 84, 698–705, May 15, 2009
Figure 3. Mutations Identified in the ALX3 Gene
(A) DNA-sequence chromatograms (above) and confirmatory restriction digests (below) of the seven different mutations identified in this
work.
(B) Cartoon showing (top) genomic organization ofALX3 (numbers above boxes indicate cDNA numbering at exon boundaries; numbers below
lines indicate intron sizes) and (middle)domainorganization of the protein.39 At bottom is shown the positionof individualmutationswithin
the homeodomain of ALX3, compared with other proteins from the Paired class (human ALX4 and ALX1,Drosophila al, human PAX6) and repre-
sentative examples of increasingly divergent human homeodomain proteins from the other major classes (HOXD13, ANTP class; LMX1B, LIM
class; POU3F4, POU class; TGIF, TALE class; and ZEB2, ZF class).21 Dashes indicate residues conserved with respect to human ALX3.The American Journal of Human Genetics 84, 698–705, May 15, 2009 701
Table 1. Mutation Details and Clinical Features of Subjects with ALX3 Mutation
Sample
ID Subject Family Sexa
Country
of Origin
Reported
Consan guinitya
Exon (Intron)
Number
Nucleotide Change
(All Homozygous)
Predicted Amino
Acid Change
Additional Clinical
Featuresa
4143 1 1 M Morocco N (2) 595-2A > T * Cleft palate, bony
defect of anterior
cranial fossa with
recurrent meningitis
4144 2 1 F Morocco N (2) 595-2A > T * Cleft palate,
convergent squint
4150 3 2 M Algeria Y 3 608A > G N203S Accessory suture
in occipital bone
4179 4 3 M Ireland Y 2 502C > G L168V R eyelid ptosis,
strabismus, choanal
stenosis, midline
philtral pit
connected to
dermoid cyst
4180 5 3 F Ireland Y 2 502C > G L168V Lipoma of corpus
callosum,
paramedian frontal
bone cysts, midline
philtral pit
connected to
dermoid cyst,
midline cleft
of upper lip
4254 6 4 F Netherlands N 2 547C > T R183W R iris coloboma,
orbital dystopia
4252 7 5 F Netherlands N 2 543T > A Y181X R eyelid ptosis,
scoliosis
4251 8 5 F Netherlands N 2 543T > A Y181X R eyelid ptosis,
lumbar lordosis
4295 9 6 M Turkey Y 2 578_581 delCTGA T193RfsX137 -
4291 10 7 F India Y 2 586C > T R196W Rugosity behind
external ears,
notched alae nasae
4292 11 7 M India Y 2 586C > T R196W Bifid tongue,
rugosity behind
external ears
* Splice-site mutation.
a Abbreviations: F, female; M, male; N, no; R, right; and Y, yes.disturbance of fusion of the frontal andmedial nasal prom-
inences and resulting buried ectodermal components.
To explore the phenotypic range of ALX3 mutations, we
undertook DNA sequencing of ALX3 in 14 additional
unrelated individuals with various FNMs. These included
one individual who was reported to have possible Pai
syndrome (MIM 155145)28, one with oculoauriculofronto-
nasal syndrome (MIM 601452)29, three with acromelic fron-
tonasal dysostosis (MIM 603671)30,31, and nine withmiscel-
laneous combinationsofhypertelorism, facial tags, andfacial
clefting6; none of these individuals exhibited ALX3 muta-
tions. DNA sequencing of ALX3 in 93 patients with nonsyn-
dromic cleft lip and/or palate also gave normal results.
We conclude that the phenotypic range from homozy-
gous loss-of-function of ALX3 appears to be narrow and is
characterized by the distinctive facial appearance shown
inFigure 1;no genotype-phenotype correlation is apparent.
Themajor features characterizing this disorder are hyperte-
lorism, wide nasal bridge, short nasal ridge, splayed nasal702 The American Journal of Human Genetics 84, 698–705, May 15bones with biﬁd nasal tip, broad columella that attaches
to the face above the alae, widely separated slit-like nares,
long philtrum, prominent philtral ridges that sometimes
have additional bilateral swellings that run into the nares,
andmidline notch in the upper lip and alveolus. Additional
features present in some patients were upper eyelid ptosis
(three subjects), inclusion dermoids of craniofacial struc-
tures, philtral pits or rugose folding behind the ears (two
subjects each), and iris coloboma, strabismus, and lipoma
of the corpus callosum (one subject each). Review of skull
radiographs or computed tomographic (CT) scans of ﬁve
subjects (1, 3, 5, 6, and 8) did not show craniosynostosis;
an accessory suture in the occipital bone was present in
subject 3 (Figure 1E). Of clinical signiﬁcance, subject 1 had
six episodes of pneumococcal meningitis, whichwere asso-
ciated with rhinorrhea of cerebrospinal ﬂuid and were
found to be related to multiple defects in the cribriform
plate of the ethmoid bone (Figure 1B); subject 5 had several
subcutaneous forehead swellings associated with, 2009
Figure 4. Dense Surface-Modeling Analysis of Subjects 4 and 5
Subject 4 (above, postoperative after insertion of nasal silastic strut, aged 10 years) and subject 5 (below, prior to nasal augmentation,
aged 5 years) were compared, in terms of lateral, vertical and depth displacement, to average faces of appropriately age- and sex-matched
controls. Green regions coincide on both patient and average face. Red regions indicate displacement of parts of the subject’s face in
a direction more rightward, downward, or inward, and blue regions indicate displacement in a direction more leftward, upward, or
outward. Color coding is shown on the accompanying scales. Note that subject 5 has greater hypertelorism and midfacial hypoplasia
than subject 4.paramedian foraminae in the frontalbone, suggestiveofder-
moids (Figure 1F). Growth and development have been
normal inall subjects,butmosthave required surgicalproce-
dures for improved appearance and function. These have
included multiple nasal reconstructions (involving 12 and
13 separate procedures, respectively, in subjects 8 and 7),
ptosis correction (subjects 6, 7, and8), strabismus correction
(subject 2), excision of dermoid cysts (subjects 4 and 5), cleft
palate repair (subjects 1 and 2), midline cleft-lip repair
(subject 5), Le Fort I advancement of maxilla (subjects 1
and 6), Le Fort III advancement and medialization of orbits
(subjects 1 and 7), and repair of the anterior cranial-base
defect and reconstruction of the nasal airway (subject 1).
The craniofacial phenotype associated with ALX3muta-
tions seems to represent a poorly recognized clinical entity.
Subjects 4 and 5 were previously described18, but similar
patients arenot illustrated inanyof the literature classifying
the diverse presentations of FNM.3–9 Lees et al.18 drew
attention to the resemblance of the affected siblings in their
report to a unique family with a phenotype named cranio-
rhiny (MIM123050).32 Although it has not beenpossible to
trace the originally reported craniorhiny family for genetic
analysis, three considerations argue that the ALX3-muta-
tion-positive subjects have adifferent condition. First, there
is differing facial morphology in craniorhiny, in which
nasal outgrowth ismuchbetter preserved; second, craniosy-
nostosis was observed in several individuals with cranio-
rhiny but is not documented in association with ALX3
mutations; third, vertical transmission suggesting domi-
nant inheritance was described in craniorhiny,32 whereas
ALX3 mutations exhibit recessive inheritance. The nasalThe Amappearance in our subjects is reminiscent to the family
reported by Fryburg et al. (MIM 305645)33, but the pheno-
type in that family also showed vertical transmission. A
possible match is the proband in the report by Toriello
et al. (MIM 164000)34; this individual shows a similar nasal
appearance to subject 7, was the offspring of a consanguin-
eous union, andhadwhiteDutch ancestry, like subjects 6–8
in our series. Otherwise, our attempts to identify patients in
the literature whomatch those reported here have, surpris-
ingly, failed. Hence, to our knowledge this is a new genetic
syndrome of FNM, for which we suggest the name fronto-
rhiny. Although acknowledging the mixed etymological
origin of this term, we believe that it best encompasses
the characteristic combination of frontal and nasal malfor-
mations in affected individuals (Figures 1 and 4) and the
clinical overlap with previously described craniorhiny.18,32
As previously noted, Alx3/ mice are phenotypically
normal, indicating a greater requirement for ALX3 in
development of the frontonasal region in the human
than in themouse. However, both Alx3 and the paralogous
gene Alx4 are expressed in the frontonasal mesenchyme at
embryonic days (E) 9.5-11.5 in the mouse, and mice
mutant for three alleles of these two genes (either Alx3/;
Alx4þ/lst-J or Alx3þ/;Alx4lst-J/lst-J) exhibit facial clefting.16
This was correlated with increased apoptosis of the devel-
oping frontonasal mesenchyme at E10.0, suggesting that
the primary defect in combined Alx3 and Alx4 deﬁciency
is failure to support normal cell survival in part of the fron-
tonasal process during a critical period of development. In
humans, heterozygous mutations of ALX4 (MIM 605420)
cause parietal foramina (PFM2 [MIM 609597]).35,36 Weerican Journal of Human Genetics 84, 698–705, May 15, 2009 703
conﬁrmed by DNA sequencing and MLPA (Tables S1 and
S2) that there were no mutations or deletions of either
ALX4 or the paralogous ALX1 gene ([MIM 601527]; previ-
ously termed CART1)37 in the ALX3-mutated individuals.
We attempted to compare the expression patterns of
ALX3 and ALX4 in the frontonasal prominences of human
embryos. We were unable to obtain signals above back-
ground for ALX3, but we observed apparent expression
of ALX4 in the medial nasal processes of an embryo at
Carnegie stage 16, equivalent to ~37 days post fertilization
(Figure S1). This excludes a mechanism whereby the
abnormal frontonasal phenotype in ALX3-deﬁcient hu-
mans, comparedtomice, is simplyattributable toacomplete
lack of ALX4 expression in the medial nasal process of the
human embryo and the resulting absolute dependence on
ALX3 expression. Our analysis does not, however, exclude
a more subtle effect involving the relative timing and levels
of ALX3 and ALX4 in the developing facial structures.
In conclusion, we have identiﬁed a recurrent pattern of
FNMthat is causedby recessivemutations in thehomeobox
gene ALX3. This is the ﬁrst isolated FNM shown to have
a speciﬁc genetic etiology, as opposed to arising from
aprenatal developmental insult. It is important to recognize
this disorder, for which we propose the term frontorhiny,
because of its speciﬁc implications for diagnostic testing
and genetic counselling and association with congenital
dermoid cysts with the potential for transcranial extension.
Our work also illustrates the power of homozygosity
mapping to identify rare recessive disease genes from very
few samples of uncertain consanguineous origin.38
Supplemental Data
Supplemental data comprise one ﬁgure, two tables, and two
movies and can be found with this article online at http://www.
ajhg.org/.
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